Gastroenterology · Anniston, AL
NPI
1356340020
Since 2005
Specialty
Gastroenterology
Code 174400000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
901 Leighton Ave, Suite 101
Anniston, AL, 36207
Phone (256) 236-0890
Groups this clinician bills Medicare through
Medicare paid, 2024
$80K
1,100 services
Medicare patients, 2024
369
Average age 73
Drug cost, 2024
$844K
5,175 prescriptions
Company payments, 2025
$1,412
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James S Hixon was code 99214 (office e&m - established), 109 times for 91 patients. In total James S Hixon billed 1,100 services in 52 codes, and Medicare paid $80K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 109 | 91 | $77.44 | $8,441 |
| 82272 Immunoassay | Office | 95 | 88 | $4.11 | $391 |
| 43249 Upper GI Endoscopy | Facility | 94 | 90 | $88.50 | $8,319 |
| 43239 Upper GI Endoscopy | Facility | 89 | 84 | $41.09 | $3,657 |
| 99204 Office E&M - New | Office | 86 | 86 | $101.52 | $8,731 |
| 76700 Ultrasound - Abdomen and Pelvis | Office | 78 | 73 | $72.92 | $5,688 |
| 43235 Upper GI Endoscopy | Facility | 73 | 60 | $68.43 | $4,995 |
| 45378 Lower GI Endoscopy - Other | Facility | 62 | 62 | $116.96 | $7,251 |
| 83013 Clinical Chemistry | Office | 55 | 55 | $64.93 | $3,571 |
| 83014 Clinical Chemistry | Office | 55 | 55 | $7.57 | $417 |
| 99213 Office E&M - Established | Office | 44 | 40 | $61.95 | $2,726 |
| 45385 Colonoscopy - Lesion Removal | Facility | 39 | 39 | $147.32 | $5,745 |
| 45380 Lower GI Endoscopy - Other | Facility | 37 | 37 | $86.18 | $3,189 |
| 99203 Office E&M - New | Office | 24 | 24 | $70.69 | $1,697 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 18 | 18 | $156.10 | $2,810 |
By year: 2022 $163K for 2,053 services; 2023 $109K for 1,374 services; 2024 $80K for 1,100 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82272 Immunoassay | 95 | 88 | $4.11 | $391 |
| 83013 Clinical Chemistry | 55 | 55 | $64.93 | $3,571 |
| 83014 Clinical Chemistry | 55 | 55 | $7.57 | $417 |
Medicare prescription drug claims, 2024
In 2024, the drug James S Hixon prescribed most often to Medicare patients was Pantoprazole Sodium, with 1,554 prescriptions and refills. In total James S Hixon wrote 5,175 Medicare prescriptions that cost $844K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 1,554 | 4,270 | 568 | $18K |
| Dicyclomine Hcl Generic | 926 | 1,826 | 316 | $36K |
| Sucralfate Generic | 504 | 790 | 363 | $19K |
| Loperamide Loperamide Hcl | 318 | 352 | 115 | $7,834 |
| Bethanechol Chloride Generic | 260 | 471 | 88 | $23K |
| Omeprazole Generic | 240 | 661 | 89 | $4,265 |
| Esomeprazole Magnesium Generic | 190 | 468 | 63 | $15K |
| Sulfasalazine Generic | 174 | 370 | 58 | $5,567 |
| Metronidazole Generic | 142 | 142 | 130 | $1,271 |
| Balsalazide Disodium Generic | 74 | 106 | 17 | $14K |
| Ondansetron Hcl Generic | 62 | 62 | 29 | $338 |
| Linzess Linaclotide | 60 | 100 | 16 | $52K |
| Hydrocortisone Generic | 58 | 58 | 47 | $956 |
| Procto-Med Hc Hydrocortisone | 54 | 54 | 48 | $1,031 |
| Scopolamine Generic | 45 | 45 | 13 | $2,238 |
Brand drugs: - claims; generic drugs: 4,694 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James S Hixon $1,412 ($1,412 in general payments such as food, travel and fees) from 13 companies. The largest payer was Pfizer Inc. with $267.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 18 | $267 |
| Madrigal Pharmaceuticals MDGL | 13 | $264 |
| CONMED Corporation CNMD | 9 | $222 |
| Janssen Biotech, Inc. JNJ | 8 | $164 |
| Phathom Pharmaceuticals, Inc. PHAT | 8 | $156 |
| Ardelyx, Inc. ARDX | 4 | $89.02 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $74.4 |
| Abbvie Inc. ABBV | 3 | $45.03 |
| Gilead Sciences, Inc. GILD | 2 | $39.43 |
| Novo Nordisk Inc NVO | 2 | $31.92 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.